Name: Curcumin-Based Nanomedicines as Cancer Therapeutics (en Inglés)
Price: 535652.00 COP
Availability: InStock
Author: Sahebkar, Amirhossein ; Kesharwani, Prashant
ISBN: 9780443154126

portada Curcumin-Based Nanomedicines as Cancer Therapeutics (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Sahebkar, Amirhossein ; Kesharwani, Prashant

Idioma

Inglés

N° páginas

490

Encuadernación

Tapa Blanda

ISBN13

9780443154126

Categorías

Investigación operativa
Software empresarial

Curcumin-Based Nanomedicines as Cancer Therapeutics (en Inglés)

Sahebkar, Amirhossein ; Kesharwani, Prashant (Autor) · Academic Press · Tapa Blanda

Libro Físico

$ 535.652

$ 892.754

Ahorras: $ 357.102

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 20 de Junio y el Viernes 28 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Curcumin-Based Nanomedicines as Cancer Therapeutics (en Inglés)"

Curcumin-based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel applications of nanocurcumin in biological milieu as well as helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries. Nanocurcumin has been widely explored for the treatment of various cancers; however, the scientific literature is inconsistent in style and structure and scattered across many sources. By providing an explicit account on vital aspects on nanocurcumin-based anticancer delivery approaches and discussing the perspectives of the technologies explored so far based upon the findings outlined, the book offers updated and in-depth knowledge on the topic in one single source written by global leading experts. In addition, the book aims to stimulate the interest of the academic researchers, industrial scientists, businessmen, and young scholars to address key multidisciplinary challenges faced by nanotechnologists to foster the desired collaboration among biologists, chemists, physicists, engineers, and clinicians to find proper and efficient new cancer treatments.